NORTHWAY BIOSANTARA
LIVE

Serial Number

79299846

Owner

UAB "Northway turto valdymas"

Attorney

John Zaccaria

Filing Date

Nov 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NORTHWAY BIOSANTARA Trademark

Serial Number: 79299846 • Registration: 6861449

NORTHWAY BIOSANTARA is a trademark filed by UAB "Northway turto valdymas" on November 5, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

UAB "Northway turto valdymas" (17 trademarks)

S.Zukausko g. 21-43

Entity Type: 99

Trademark Details

Filing Date

November 5, 2020

Registration Date

October 4, 2022

Published for Opposition

October 19, 2021

Goods & Services

Pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 14, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 23, 2023 FICS
FINAL DISPOSITION PROCESSED
Jan 23, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 4, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 4, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 4, 2022 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Aug 24, 2022 TMBN
OPPOSITION TERMINATED NO. 999999
Aug 24, 2022 OP.T
OPPOSITION DISMISSED NO. 999999
Aug 24, 2022 OP.D
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 6, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 19, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 18, 2022 OPNR
REFUSAL PROCESSED BY IB
Dec 6, 2021 RFNT
OPPOSITION INSTITUTED NO. 999999
Nov 20, 2021 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Nov 8, 2021 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Nov 6, 2021 OPNC
OPPOSITION PAPERS RECEIVED AT TTAB
Nov 5, 2021 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 19, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2021 CNSA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 15, 2021 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jul 16, 2021 NREP
REFUSAL PROCESSED BY IB
Apr 13, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 22, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 17, 2020 REPR